Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4539310
Max Phase: Preclinical
Molecular Formula: C25H32N2O4
Molecular Weight: 424.54
Molecule Type: Unknown
Associated Items:
ID: ALA4539310
Max Phase: Preclinical
Molecular Formula: C25H32N2O4
Molecular Weight: 424.54
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCc1c(OC)cc(OC)c(C(=O)/C=C/c2cccc(N3CCNCC3)c2)c1O
Standard InChI: InChI=1S/C25H32N2O4/c1-4-5-9-20-22(30-2)17-23(31-3)24(25(20)29)21(28)11-10-18-7-6-8-19(16-18)27-14-12-26-13-15-27/h6-8,10-11,16-17,26,29H,4-5,9,12-15H2,1-3H3/b11-10+
Standard InChI Key: YGIMGQXXPNYGDY-ZHACJKMWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 424.54 | Molecular Weight (Monoisotopic): 424.2362 | AlogP: 4.06 | #Rotatable Bonds: 9 |
Polar Surface Area: 71.03 | Molecular Species: BASE | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.48 | CX Basic pKa: 8.80 | CX LogP: 4.30 | CX LogD: 4.11 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.47 | Np Likeness Score: 0.31 |
1. Yin H, Dong J, Cai Y, Shi X, Wang H, Liu G, Tang Y, Liu J, Ma L.. (2019) Design, synthesis and biological evaluation of chalcones as reversers of P-glycoprotein-mediated multidrug resistance., 180 [PMID:31325783] [10.1016/j.ejmech.2019.05.053] |
Source(1):